[Progressive familial intrahepatic cholestasis type 3]

Area of Science:

• Genetics and Molecular Biology
• Hepatology
• Pediatric Gastroenterology

Background:

• Progressive familial intrahepatic cholestasis (PFIC) encompasses genetic disorders affecting bile flow.
• Mutations in the ABCB4 gene are implicated in PFIC type 3, an autosomal recessive condition.
• Approximately 200 cases of hepatobiliary disorders linked to ABCB4 mutations are documented.

Purpose of the Study:

• To review the pathogenesis of PFIC type 3.
• To outline the clinical presentation and diagnostic approaches for PFIC type 3.
• To summarize current treatment strategies for PFIC type 3.

Main Methods:

• Literature review of studies on PFIC type 3.
• Analysis of pathogenesis, clinical manifestations, diagnostics, and treatment.

Main Results:

• ABCB4 gene mutations disrupt bile canalicular membrane function.
• Clinical spectrum includes cholestasis, jaundice, and liver damage.
• Diagnosis relies on genetic testing and liver biopsy findings.

Conclusions:

• Understanding ABCB4 mutations is crucial for diagnosing and managing PFIC type 3.
• Early diagnosis and tailored treatment improve patient outcomes.
• Further research is needed to optimize therapeutic interventions.